The book Discovering the Nature of Longevity chronicles how thousands of patients are benefiting when damage inflicted by hidden stress on the heart and body is targeted.1 This ‘hidden’ stress includes hard-to-detect, low-levels of heavy metals and stealthy infections that were not considered to be heart disease risk factors, until the American Heart Association recently declared heavy metals to be exactly that. These provoke oxidative stress that attack the body early in life, triggering a life-long vicious cycle of injury and inflammation leading to hardening and blockage of the arteries.
A new wave of therapies is emerging that targets the damage from those stresses. One is a compound known by the trade name NanobacTX. In this Companion publication to Discovering the Nature of Longevity (abbreviated here as DNOL),I describe the first-hand accounts by doctors and their patients of results with the compound. Much of that success is due to the tenacity of its inventor, Gary Mezo, who weathered a 20-year ordeal of regulatory, medical, and financial barriers in order to continue providing it. His story is told here.
0 Comments